Cumberland Pharmaceuticals CPIX Kristalose — Non-current inventories
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Cumberland Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InventoryNoncurrent.
The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cumberland Pharmaceuticals's kristalose — non-current inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Cumberland Pharmaceuticals's kristalose — non-current inventories?
- Cumberland Pharmaceuticals (CPIX) reported kristalose — non-current inventories of $2.26M in Q1 2026.
- How has Cumberland Pharmaceuticals's kristalose — non-current inventories changed year-over-year?
- Cumberland Pharmaceuticals's kristalose — non-current inventories decreased by 6.5% year-over-year, from $2.42M to $2.26M.
- What does kristalose — non-current inventories mean?
- This metric measures the value of Kristalose-related inventory that is not expected to be sold or converted into cash within the next twelve months. It reflects long-term supply chain positioning and potential obsolescence risks associated with the product's lifecycle.